tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ATOS Stock Latest News

Atossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen
Press ReleasesAtossa Therapeutics Announces Expanded Research Agreement with Weill Cornell Medicine to Further Evaluate Synergy Between Antibody Drug Conjugates (ADCs) and (Z)-Endoxifen
14h ago
ATOS
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
PremiumPress Releases
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
15d ago
ATOS
Atossa Therapeutics, Quantum Leap announces initiation of I-SPY 2 trial
PremiumThe Fly
Atossa Therapeutics, Quantum Leap announces initiation of I-SPY 2 trial
15d ago
ATOS
Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference
PremiumPress Releases
Atossa to Participate in Noble Capital Markets Emerging Growth Healthcare Conference
19d ago
ATOS
Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen
PremiumPress Releases
Atossa Therapeutics Presents Data from 40mg Cohort of Phase 2 EVANGELINE Clinical Trial Showing 100% Disease Control Rate After 24-Weeks of Treatment with (Z)-Endoxifen
20d ago
ATOS
Atossa Therapeutics presents data from 40mg cohort of Phase 2 EVANGELINE trial
PremiumThe FlyAtossa Therapeutics presents data from 40mg cohort of Phase 2 EVANGELINE trial
20d ago
ATOS
Navigating Choppy Waters: Atossa Therapeutics’ Struggle with Compliance Costs and Business Performance
PremiumCompany Announcements
Navigating Choppy Waters: Atossa Therapeutics’ Struggle with Compliance Costs and Business Performance
27d ago
ATOS
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Atossa Therapeutics Announces Year-End 2023 Financial Results and Provides Corporate Update
28d ago
ATOS
Is ATOS a Buy, Before Earnings?
PremiumPre-Earnings
Is ATOS a Buy, Before Earnings?
1M ago
ATOS
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
ATOS
BCEL
Atossa Therapeutics provides five-year (Z)-endoxifen update
PremiumThe Fly
Atossa Therapeutics provides five-year (Z)-endoxifen update
1M ago
ATOS
Atossa Therapeutics provides five-year Z-Endoxifen treatment update
PremiumThe Fly
Atossa Therapeutics provides five-year Z-Endoxifen treatment update
1M ago
ATOS
Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved “Expanded Access” Program for a U.S. Breast Cancer Patient
PremiumPress ReleasesAtossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved “Expanded Access” Program for a U.S. Breast Cancer Patient
1M ago
ATOS
Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
PremiumPress Releases
Atossa Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Listing Requirements
1M ago
ATOS
Atossa Therapeutics regains compliance with Nasdaq minimum bid price rule
PremiumThe Fly
Atossa Therapeutics regains compliance with Nasdaq minimum bid price rule
1M ago
ATOS
Atossa Therapeutics Appoints Dr. Cigler, Expands Board Governance
PremiumCompany Announcements
Atossa Therapeutics Appoints Dr. Cigler, Expands Board Governance
2M ago
8K
ATOS
Atossa Therapeutics appoints Tessa Cigler to board of directors
PremiumThe Fly
Atossa Therapeutics appoints Tessa Cigler to board of directors
2M ago
ATOS
Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors
PremiumPress Releases
Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors
2M ago
ATOS
Atossa Therapeutics announces first patient dosing of Z-endoxifen
PremiumThe Fly
Atossa Therapeutics announces first patient dosing of Z-endoxifen
2M ago
ATOS
Atossa Therapeutics initiated with a Buy at H.C. Wainwright
PremiumThe FlyAtossa Therapeutics initiated with a Buy at H.C. Wainwright
3M ago
ATOS
Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial
PremiumPress Releases
Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial
3M ago
ATOS
Atossa announces full enrollment of Z-endoxifen arm of I-SPY 2 trial
PremiumThe Fly
Atossa announces full enrollment of Z-endoxifen arm of I-SPY 2 trial
3M ago
ATOS

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >